Morgan Stanley maintains Incyte at Equalweight, PT $74.00

  • Investing.com
Morgan Stanley maintains Incyte at Equalweight, PT $74.00

A Morgan Stanley analyst maintained Incyte (NASDAQ: INCY) at Equalweight and a price target of $74.00 from a prior price target of %currency%%price%.

Prior to this rating, Incyte had 10 buy ratings, 11 hold ratings, and 0 sell ratings.

For consensus analyst estimates and price targets on Incyte, click here. For more news on Incyte, click here.

Incyte's stock price closed at $69.96. They are down -3.7% in the last month and down -13.33% in the last 12 months.

According to Investing Pro, Incyte's fair value is $97.56, an upside of 39.45%. Incyte's fair value comes with a low degree of uncertainty, according to InvestingPro.

Check out Incyte's recent earnings performance and financials here.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles